drugset / Trial / NCT00000541

Women's Antioxidant and Folic Acid Cardiovascular Study (WAFACS)

NCT00000541 ↗

RandomizedFactorialPrevention

Summary

To determine if supplements of vitamin C, vitamin E, beta-carotene, and B-vitamins (a combination of folic acid, vitamins B6 and B12) reduce risk of major cardiovascular events in high risk women with a prior history of atherosclerotic cardiovascular disease. The trial is a companion to the Women's Health Study (WHS), a primary prevention trial of vitamin E and aspirin in a low risk population of women.

Timeline

Start
1993-05
Primary completion
2005-07
Completion
2005-07

Outcome

Missed primary endpoint

paper a combination pill of folic acid, vitamin B6, and vitamin B12 did not reduce a combined end point of total cardiovascular events among high-risk women PMID 18460663 ↗

paper There were no overall effects of ascorbic acid, vitamin E, or beta carotene on cardiovascular events among women at high risk for CVD. PMID 17698683 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Pyridoxine Unknown 50 mg —
Subject Vitamin B12 Other / unclassified 1 mg —
Subject Vitamin C Other / unclassified 500 mg —
Subject alpha-tocopherol Unknown 600 iu —
Subject beta-carotene Small molecule 50 mg —
Subject folic acid Other / unclassified 2.5 mg —